A randomized, open label, clinical trial of the pharmacokinetics of azithromycin in serum, bronchial washings and lung tissue following a single dose of azithromycin sustained release (2 gram) or commercial azithromycin tablet (500 mg) to cancer patients that require lung resection

Trial Profile

A randomized, open label, clinical trial of the pharmacokinetics of azithromycin in serum, bronchial washings and lung tissue following a single dose of azithromycin sustained release (2 gram) or commercial azithromycin tablet (500 mg) to cancer patients that require lung resection

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Respiratory tract infections
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top